Race Oncology Ltd. (AU:RAC) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Race Oncology Ltd has released a video recording of its 2024 Annual General Meeting, highlighting their progress in advancing bisantrene, a promising chemotherapeutic with reduced cardiotoxicity. The company is actively exploring partnerships to expand global access to its treatments and address unmet needs in cancer care. Investors are encouraged to access the AGM video for detailed insights into Race’s strategic plans and collaborations.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.